Stifel raises Viking Therapeutics price target citing strong portfolio By Investing.com
© Reuters. On Wednesday, Stifel, a financial services firm, raised its price target for Viking Therapeutics (NASDAQ:) to $35 from ...
© Reuters. On Wednesday, Stifel, a financial services firm, raised its price target for Viking Therapeutics (NASDAQ:) to $35 from ...
© Reuters. Viavi Solutions (VIAV) surges 15% following Stifel upgrade Shares of Viavi Solutions (NASDAQ:) surged more than 15% Monday ...
Copyright © 2022 - Index Investing News.
Index Investing News is not responsible for the content of external sites.